Veerendra Munugalavadla
ORCID：0000-0002-2390-3822
发表论文 154 篇 · 总被引 3054 次 · h-index 29
代表论文
- Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia (2025 · New England Journal of Medicine · 被引 121)
- Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN (2023 · Blood · 被引 52)
- Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib (2024 · Blood · 被引 49)
- Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN (2025 · Blood · 被引 47)
- Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis (2024 · Blood Advances · 被引 28)
- Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment (2023 · Clinical Cancer Research · 被引 28)